BACKGROUND: Early brain overgrowth (EBO) in autism spectrum disorder (ASD) is among the best replicated biological associations in psychiatry. Most positive reports have compared head circumference (HC) in ASD (an excellent proxy for early brain size) with well-known reference norms. We sought to reappraise evidence for the EBO hypothesis given 1) the recent proliferation of longitudinal HC studies in ASD, and 2) emerging reports that several of the reference norms used to define EBO in ASD may be biased toward detecting HC overgrowth in contemporary samples of healthy children. METHODS: Systematic review of all published HC studies in children with ASD. Comparison of 330 longitudinally gathered HC measures between birth and 18 months from male children with autism (n = 35) and typically developing control subjects (n = 22). RESULTS: In systematic review, comparisons with locally recruited control subjects were significantly less likely to identify EBO in ASD than norm-based studies (p < .001). Through systematic review and analysis of new data, we replicate seminal reports of EBO in ASD relative to classical HC norms but show that this overgrowth relative to norms is mimicked by patterns of HC growth age in a large contemporary community-based sample of US children (n ~ 75,000). Controlling for known HC norm biases leaves inconsistent support for a subtle, later emerging and subgroup specific pattern of EBO in clinically ascertained ASD versus community control subjects. CONCLUSIONS: The best-replicated aspects of EBO reflect generalizable HC norm biases rather than disease-specific biomarkers. The potential HC norm biases we detail are not specific to ASD research but apply throughout clinical and academic medicine. Published by Elsevier Inc on behalf of Society of Biological Psychiatry.
BACKGROUND: Early brain overgrowth (EBO) in autism spectrum disorder (ASD) is among the best replicated biological associations in psychiatry. Most positive reports have compared head circumference (HC) in ASD (an excellent proxy for early brain size) with well-known reference norms. We sought to reappraise evidence for the EBO hypothesis given 1) the recent proliferation of longitudinal HC studies in ASD, and 2) emerging reports that several of the reference norms used to define EBO in ASD may be biased toward detecting HC overgrowth in contemporary samples of healthy children. METHODS: Systematic review of all published HC studies in children with ASD. Comparison of 330 longitudinally gathered HC measures between birth and 18 months from male children with autism (n = 35) and typically developing control subjects (n = 22). RESULTS: In systematic review, comparisons with locally recruited control subjects were significantly less likely to identify EBO in ASD than norm-based studies (p < .001). Through systematic review and analysis of new data, we replicate seminal reports of EBO in ASD relative to classical HC norms but show that this overgrowth relative to norms is mimicked by patterns of HC growth age in a large contemporary community-based sample of US children (n ~ 75,000). Controlling for known HC norm biases leaves inconsistent support for a subtle, later emerging and subgroup specific pattern of EBO in clinically ascertained ASD versus community control subjects. CONCLUSIONS: The best-replicated aspects of EBO reflect generalizable HC norm biases rather than disease-specific biomarkers. The potential HC norm biases we detail are not specific to ASD research but apply throughout clinical and academic medicine. Published by Elsevier Inc on behalf of Society of Biological Psychiatry.
Entities:
Keywords:
Autism; CDC; WHO; bias; head circumference; systematic review
Authors: Eric Courchesne; Peter R Mouton; Michael E Calhoun; Katerina Semendeferi; Clelia Ahrens-Barbeau; Melodie J Hallet; Cynthia Carter Barnes; Karen Pierce Journal: JAMA Date: 2011-11-09 Impact factor: 56.272
Authors: John N Constantino; Palak Majmudar; Alex Bottini; Molly Arvin; Yamini Virkud; Paul Simons; Ed Spitznagel Journal: J Neurodev Disord Date: 2010-03 Impact factor: 4.025
Authors: Marwan Shinawi; Pengfei Liu; Sung-Hae L Kang; Joseph Shen; John W Belmont; Daryl A Scott; Frank J Probst; William J Craigen; Brett H Graham; Amber Pursley; Gary Clark; Jennifer Lee; Monica Proud; Amber Stocco; Diana L Rodriguez; Beth A Kozel; Steven Sparagana; Elizabeth R Roeder; Susan G McGrew; Thaddeus W Kurczynski; Leslie J Allison; Stephen Amato; Sarah Savage; Ankita Patel; Pawel Stankiewicz; Arthur L Beaudet; Sau Wai Cheung; James R Lupski Journal: J Med Genet Date: 2009-11-12 Impact factor: 6.318
Authors: C M Wright; I W Booth; J M H Buckler; N Cameron; T J Cole; M J R Healy; J A Hulse; M A Preece; J J Reilly; A F Williams Journal: Arch Dis Child Date: 2002-01 Impact factor: 3.791
Authors: Gregory L Wallace; Ian W Eisenberg; Briana Robustelli; Nathan Dankner; Lauren Kenworthy; Jay N Giedd; Alex Martin Journal: J Am Acad Child Adolesc Psychiatry Date: 2015-03-17 Impact factor: 8.829
Authors: Oliver D Howes; Maria Rogdaki; James L Findon; Robert H Wichers; Tony Charman; Bryan H King; Eva Loth; Gráinne M McAlonan; James T McCracken; Jeremy R Parr; Carol Povey; Paramala Santosh; Simon Wallace; Emily Simonoff; Declan G Murphy Journal: J Psychopharmacol Date: 2017-12-14 Impact factor: 4.153
Authors: Alan S Brown; David Gyllenberg; Susanna Hinkka-Yli-Salomäki; Andre Sourander; Ian W McKeague Journal: Schizophr Res Date: 2016-11-04 Impact factor: 4.939
Authors: Mark D Shen; Christine W Nordahl; Deana D Li; Aaron Lee; Kathleen Angkustsiri; Robert W Emerson; Sally J Rogers; Sally Ozonoff; David G Amaral Journal: Lancet Psychiatry Date: 2018-09-27 Impact factor: 27.083
Authors: Amanda E Lyall; Feng Shi; Xiujuan Geng; Sandra Woolson; Gang Li; Li Wang; Robert M Hamer; Dinggang Shen; John H Gilmore Journal: Cereb Cortex Date: 2014-03-02 Impact factor: 5.357